Showing 20 of 86 recruiting trials for “myasthenia-gravis”
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
RecruitingNCT06909253 ↗
Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis
Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
Immediate Corticosteroid Therapy and Rituximab to Prevent Generalization in Ocular Myasthenia: a PROBE Multicenter Open-label Randomized Controlled Trial.
Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis
A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)
Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases
👨⚕️ Qiang Liu, M.D.,Ph.D, Tianjin Medical University General Hospital📍 1 site📅 Started Apr 2025View details ↗
RecruitingNCT06743490 ↗
Capturing Key MG-symptoms Using Smartphone Recordings.
👨⚕️ Martijn R. Tannemaat, MD, PhD, Leiden University Medical Center📍 2 sites📅 Started Mar 2025View details ↗
Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod
RecruitingNCT06815133 ↗
Effectiveness and Safety of Zilucoplan Treatment for French Patients With Myasthenia Gravis Over 3 Months
RecruitingNCT06866483 ↗
Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
Efgartigimod in IVIG Dependent Myasthenia Gravis Patients
Enrolling by InvitationNCT06877403 ↗
Prevalence and Impact of Fatigue in Myasthenic Patients Followed At Clermont-Ferrand University Hospital - "My" Asthenia
A Study to Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR T-cells in Patients With Refractory Generalized Myasthenia Gravis
Interventions Against Fatigue in Patients With Myasthenia Gravis
👨⚕️ Martijn R. Tannemaat, MD, PhD, Leiden University Medical Center📍 1 site📅 Started Dec 2024View details ↗
An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis
RecruitingNCT06298565 ↗
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →